Michael Sassano is a respected executive in the pharmaceutical cannabis industry and an early investor in the US cannabis industry. He's celebrated for his expertise in developing large-scale cannabis infrastructures and advanced pharmaceutical cannabinoid products, and for predicting long-term cannabis market trends. Previously, Michael led a successful merger of his cannabis cultivation company, Solaris Farms, with The Sanctuary, and he remains on the advisory board of Solaris. He now focuses on his role as CEO and Chairman of the Board for Somai Pharmaceuticals LTD, a European pharmaceutical and biotech company that produces EU GMP-certified cannabinoid-containing pharmaceuticals with advanced product development and innovative delivery methods.

Trending